Urine Cadmium and Risk of Cardiovascular Disease
尿镉与心血管疾病的风险
基本信息
- 批准号:9234827
- 负责人:
- 金额:$ 30.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-01 至 2020-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acute myocardial infarctionAdultAgreementAnimalsAtherosclerosisBehavioralBiological MarkersBlood VesselsCadmiumCardiovascular DiseasesCardiovascular systemCessation of lifeCholesterolClinicalClinical DataCohort StudiesCotinineCreatinineDataDiabetes MellitusDoseEnvironmentEnvironmental ExposureEnvironmental Tobacco SmokeEpidemiologyEventExposure toFertilizersFoodFunctional disorderGeneral PopulationHalf-LifeHealthHeart failureHeavy MetalsHypertensionIncidenceIncidence StudyIntakeInterventionKidneyLightLinkLongitudinal StudiesMeasuresMediatingMediationMorbidity - disease rateMyocardial InfarctionOsmolalitiesOutcomeParticipantPeripheral arterial diseasePhysical activityPopulationPopulation StudyPopulations at RiskPreventionProspective cohortRecruitment ActivityResearchResearch DesignRiskRisk FactorsRoleSample SizeSamplingShapesSmokingSourceSpottingsStrokeTimeTissuesTobacco smokingTrace metalUncertaintyUrineWomanbasecardiovascular disorder riskcardiovascular risk factorcigarette smokingcohortdesigndiet and cancerdisorder riskendothelial dysfunctionenvironmental tobacco smoke exposureepidemiology studyexposed human populationfollow-uphazardhypercholesterolemiainnovationinorganic phosphateinsightmenmortalitynever smokernovelpopulation basedprospectivepublic health relevanceresponsesecondary analysisurinary
项目摘要
Abstract
Cardiovascular disease (CVD) is the major cause of morbidity and mortality in the US and globally. Despite
established risk factors for CVD, many cases remain unexplained. Cadmium is a heavy metal that has been
shown to damage vascular tissues, induce endothelial dysfunction and promote atherosclerosis in animal and
mechanistic studies. Epidemiologic studies have linked cadmium to cardiovascular endpoints such as
hypertension, peripheral arterial disease, and cardiovascular mortality. Establishing cadmium as a
cardiovascular risk factor, however, has been limited by the lack of prospective incidence studies. In addition
few studies have had sufficient statistical power to investigate the association among never smokers to
alleviate serious concerns about potential confounding by tobacco smoking. The objective of this proposed
study is to investigate the association between incident cardiovascular outcomes and cadmium exposure at
levels that are relevant to the general population among never-smokers. Human exposure to cadmium occurs
primarily via diverse food types and cigarette smoke. Following intake, cadmium is stored predominantly in the
kidney, where it remains for decades (half-life: 10-30 years). A small portion of cadmium is slowly excreted in
the urine, making urinary cadmium a well-established biomarker of long-term exposure. We will leverage
existing samples and data from the 19,000+ never-smoking participants in the prospective population-based
Danish Diet Cancer and Health Cohort which recruited participants 1993-1997 and collected urine at that time.
We will include demographic, behavioral, and clinical data from up to 20 years of follow-up to prospectively
evaluate the association between cadmium exposure and clinical cardiovascular events. Using a case-cohort
study design we will select cases of stroke (N=549), acute myocardial infarction (N=641), and heart failure
(N=761), and a comparison subcohort of 600 men and 600 women. Trace metals, creatinine, osmolality, and
cotinine will be analyzed in baseline urine samples. As a secondary Aim, we will apply mediation analyses
using a counterfactual framework based approach to estimate the extent to which cadmium’s influence on
stroke, heart failure, and acute myocardial infarction might be mediated via hypertension,
hypercholesterolemia, and diabetes. Results from the mediation analysis may help to identify additional targets
for intervention as well as aid in understanding the role of cadmium in the pathophysiology of these CVD
events. Our proposed research will be one of the first studies to quantify the association between cadmium and
incidence of cardiovascular disease in a longitudinal study with a never-smoking cohort. Sources of cadmium
in the environment are well known, including phosphate fertilizers; given widespread cadmium exposure, and
that cadmium exposure via food can be lowered by regulating fertilizer, the identification of cadmium as a
cardiovascular risk factor can have major implications for the prevention and control of cardiovascular disease.
抽象的
心血管疾病(CVD)是美国和全球发病率和死亡率的主要原因。
尽管已经确定了 CVD 的危险因素,但许多病例仍无法解释镉是一种重金属。
在动物和动物中显示会损伤血管组织,诱导内皮功能障碍并促进动脉粥样硬化
流行病学研究已将镉与心血管终点事件联系起来。
高血压、外周动脉疾病和心血管死亡率。
然而,由于缺乏前瞻性发病率研究,心血管危险因素受到限制。
很少有研究具有足够的统计能力来调查从不吸烟者与吸烟者之间的关系
对吸烟造成的潜在混淆的严重担忧 此项缓解措施的目标。
研究旨在调查心血管结局与镉暴露之间的关联
人类接触镉的水平与一般不吸烟者相关。
镉主要通过不同的食物类型和香烟烟雾摄入后储存在体内。
镉会在肾脏中保留数十年(半衰期:10-30 年)。
尿液中的镉,使尿镉成为长期暴露的成熟生物标志物。
来自 19,000 多名不吸烟参与者的现有样本和数据
丹麦饮食癌症与健康队列于 1993 年至 1997 年招募参与者并收集当时的尿液。
我们将包括长达 20 年的随访和前瞻性的人口统计、行为和临床数据
使用病例队列评估镉暴露与临床心血管事件之间的关联。
研究设计我们将选择中风(N=549)、急性心肌梗塞(N=641)和心力衰竭的病例
(N=761),以及由 600 名男性和 600 名女性组成的比较小组。
将在基线尿液样本中分析可替宁 作为次要目标,我们将应用中介分析。
使用基于反事实框架的方法来估计镉对环境的影响程度
中风、心力衰竭和急性心肌梗塞可能是通过高血压介导的,
中介分析的结果可能有助于确定其他目标。
进行干预并帮助了解镉在这些 CVD 病理生理学中的作用
我们提出的研究将是量化镉和镉之间关系的首批研究之一。
一项针对从不吸烟人群的纵向研究中心血管疾病的发病率。
环境中的镉是众所周知的,包括磷肥;以及
可以通过调节肥料来降低通过食物摄入的镉,将镉确定为一种
心血管危险因素对心血管疾病的预防和控制具有重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jaymie R Meliker其他文献
Jaymie R Meliker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jaymie R Meliker', 18)}}的其他基金
Urine cadmium and risk of fracture and bone loss
尿镉与骨折和骨质流失的风险
- 批准号:
10491320 - 财政年份:2021
- 资助金额:
$ 30.33万 - 项目类别:
Urine cadmium and risk of fracture and bone loss
尿镉与骨折和骨质流失的风险
- 批准号:
10307007 - 财政年份:2021
- 资助金额:
$ 30.33万 - 项目类别:
Urine cadmium and risk of fracture and bone loss
尿镉与骨折和骨质流失的风险
- 批准号:
10907998 - 财政年份:2021
- 资助金额:
$ 30.33万 - 项目类别:
Urine cadmium and risk of fracture and bone loss
尿镉与骨折和骨质流失的风险
- 批准号:
10687100 - 财政年份:2021
- 资助金额:
$ 30.33万 - 项目类别:
Urine cadmium and risk of fracture and bone loss
尿镉与骨折和骨质流失的风险
- 批准号:
10612697 - 财政年份:2021
- 资助金额:
$ 30.33万 - 项目类别:
Metal-nutrient mixtures in epidemiologic and toxicologic studies of cardiovascular disease
心血管疾病流行病学和毒理学研究中的金属营养混合物
- 批准号:
10254343 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
Metal-nutrient mixtures in epidemiologic and toxicologic studies of cardiovascular disease
心血管疾病流行病学和毒理学研究中的金属营养混合物
- 批准号:
10432074 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
Metal-nutrient mixtures in epidemiologic and toxicologic studies of cardiovascular disease
心血管疾病流行病学和毒理学研究中的金属营养混合物
- 批准号:
10063369 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)
治疗痛风目标血清尿酸与治疗避免症状:随机对照试验 (TRUST)
- 批准号:
10583217 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Enhancing the Efficiency of Pragmatic Clinical Trials Using Administrative Data: Analysis of the STRIDE Study
使用管理数据提高实用临床试验的效率:STRIDE 研究分析
- 批准号:
10365009 - 财政年份:2022
- 资助金额:
$ 30.33万 - 项目类别:
Enhancing the Efficiency of Pragmatic Clinical Trials Using Administrative Data: Analysis of the STRIDE Study
使用管理数据提高实用临床试验的效率:STRIDE 研究分析
- 批准号:
10588255 - 财政年份:2022
- 资助金额:
$ 30.33万 - 项目类别: